Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTK1 | Q9Y2Q3 | 2/20 | 0.42 |
| ▸ | GABRP | O00591 | 2/20 | 0.39 |
| ▸ | GABRD | O14764 | 2/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.39 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.39 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.39 |
| ▸ | GABRE | P78334 | 2/20 | 0.39 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.39 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.39 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.39 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11757509 | 0.91 | GSTK1 (0.46) | GSTK1LMNASLC22A6TSHRNFKB1 | |
| Hydrochloric Acid SCHEMBL11752458 | 0.91 | GSTK1 (0.46) | GSTK1LMNASLC22A6TSHRNFKB1 | |
| SCHEMBL29022284 | 0.88 | GABRP (0.46) | GSTK1GABRPGABRDGABRA1GABRB1 | |
| Hydrochloric Acid SCHEMBL11759753 | 0.86 | GABRP (0.45) | GSTK1GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL3125770 | 0.82 | TRPA1 (0.43) | GSTK1GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL8574433 | 0.82 | ALDH1A1 (0.40) | TSHRALDH1A1 | |
| SCHEMBL4916835 | 0.80 | — | — | |
| SCHEMBL15453265 | 0.80 | — | — | |
| SCHEMBL10336347 | 0.79 | GSTK1 (0.45) | GSTK1GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL23780014 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117384100-A | Carbendazim hapten and artificial antigen as well as preparation methods and application thereof | 河南农业大学 | 2024-01-12 | — | — | CN | disclosed |
| CN-117384100-A | Carbendazim hapten and artificial antigen as well as preparation methods and application thereof | 河南农业大学 | 2024-01-12 | — | — | CN | disclosed |
| EP-1576655-B1 | STABILIZED SEMICONDUCTOR NANOCRYSTALS | BAWENDI MOUNGI G (US) | 2014-05-21 | — | — | EP | disclosed |
| US-8481162-B2 | Stabilized semiconductor nanocrystals comprising a coating of polydentate ligand | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-07-09 | — | — | US | disclosed |
| US-20100102277-A1 | Stabilized semiconductor nanocrystals | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2010-04-29 | — | — | US | disclosed |
| US-7601424-B2 | Stabilized semiconductor nanocrystals | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2009-10-13 | — | — | US | disclosed |
| US-20070160838-A1 | Stabilized semiconductor nanocrystals | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2007-07-12 | — | — | US | disclosed |
| US-7160613-B2 | Stabilized semiconductor nanocrystals | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2007-01-09 | — | — | US | disclosed |
| EP-1576655-A2 | STABILIZED SEMICONDUCTOR NANOCRYSTALS | Bawendi, Moungi G. (US) | 2005-09-21 | — | — | EP | disclosed |
| WO-2004042784-A2 | STABILIZED SEMICONDUCTOR NANOCRYSTALS | MASSACHUSSETTS INSTITUTE OF TECHNOLOGY (US) | 2004-05-21 | — | — | WO | disclosed |
| US-20040091710-A1 | Stabilized semiconductor nanocrystals | BB BIOVENTURES L.P. | 2004-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100102277-A1 | Stabilized semiconductor nanocrystals | PDCD1LG2, PDS5B, SNCA | GSTK1 1636/4885GABRP 4051/4885GABRD 4693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.